Search
for
Sort by
Research 691–720 of 1000+
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Reversing wrinkled skin and hair loss in mice by restoring mitochondrial function
- Cutaneous Syndromes Produced as Side Effects of Triparanol Therapy
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Dermatophytosis in companion animals: A review
- Five year results of a prospective very low calorie diet or conventional weight loss programme in type 2 diabetes
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
- How should postmenopausal androgen excess be evaluated?
- DRUG‐ASSOCIATED ALOPECIA
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Epoxy Fatty Acids and Inhibition of the Soluble Epoxide Hydrolase Selectively Modulate GABA Mediated Neurotransmission to Delay Onset of Seizures
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Dissection of genetic variation and evidence for pleiotropy in male pattern baldness
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
- Brg1 Governs a Positive Feedback Circuit in the Hair Follicle for Tissue Regeneration and Repair
- Compliance With Contraceptives and Other Treatments
- Safety of testosterone use in women
- Family History and Risk of Hair Loss
- Endocrine care of transpeople part I. A review of cross-sex hormonal treatments, outcomes and adverse effects in transmen
- Mitoxantrone
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Androgens and Antiandrogens
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Anabolic-androgenic steroids and cardiovascular risk
- Prediction of male-pattern baldness from genotypes
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects